6-(2-(4-(BENZO(D)ISOTHIAZOL-3-YL)PIPERAZIN-1-YL)ETHYL)-7-CHLORO-4,4,8-TRIMETHYL-3,4-DIHYDRO-1H-QUINOLIN-2-ONE
UNII 9L2GC69RE8
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-(2-(4-(benzo(d)isothiazol-3-yl)piperazin-1-yl)ethyl)-7-chloro-4,4,8-trimethyl-3,4-dihydro-1h-quinolin-2-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9L2GC69RE8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 676116-05-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H29ClN4OS DGXZSCUMGGWVBR-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-(2-(4-(benzo(d)isothiazol-3-yl)piperazin-1-yl)ethyl)-7-chloro-4,4,8-trimethyl-3,4-dihydro-1h-quinolin-2-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.